PolarityTE: A Comprehensive Look At The Bull Vs Bear...
PolarityTE is a reverse-merger, pre-revenue, pre-clinical tissue regeneration med-tech company with a main product that's patent-pending. PolarityTE’s first product, SkinTE,...
Research
(If you're unable to access an article, contact us and we'll email you the full article)
Why Everspin Technologies Is Fading And Will Continue To...
In October 2016, Everspin (MRAM) IPOed at $8 per share and traded there until a Barron's article in May caused...
ShiftPixy Is Just A Struggling Staffing Agency, It Has...
ShiftPixy uses a social networking app to match employers with part-time "shift" employees. ShiftPixy's CEO, Scott Absher, has a checkered...
Ethema Health: A Ground Floor Opportunity In The Rapidly...
At an adjusted book value of $0.066, GRST has limited downside, and is a potential 10x bagger over time. Ethema Health...
Delcath Systems Death Spiral Financing And Luxurious Spending Will...
In the past month, Delcath has risen 1000%+ on promotional hype and no fundamental news. Delcath is engaging in death...
PDL Biopharma Is A Solid Biotech Investment In A...
Specialty pharma company PDL BioPharma has invested a lot in its acquisition of hypertension drug Tekturna, and has hired a...
If Ominto Was A Private Company It Would Be...
If Ominto Was A Private Company, It Would Be Worth A Fraction Of Its Current Price Ominto, an online cash...
Matinas BioPharma Has A Weak Drug Pipeline And Investors...
Matinas BioPharma (MTNB) is one of those rare, no-brainer, diamond in the rough, short ideas. Matinas BioPharma's stock has moved...
Straight Path Spectrum Value: The Truth Is Revealed In...
Lead attorney for Straight Path's shareholder lawsuit says Straight Path management perpetrated a "years-long fraud". "Use it or lose it"...
Corrections Corp – Delayed Bullish As Private Prisons Are...
While there has been talk of doing away with private prisons for years, investors of private prison operator stocks GEO...
Scientific Games Dominates Gaming Technology – Could Double In...
With Scientific Games large size, the recent CEO change was likely the right choice and investors should buy on current...
Why Relypsa Is Likely A Zero: The Chronic Hyperkalemia...
Hyperkalemia, or high potassium in the blood, is unnecessary to treat unless it's at a severe level. Most medicare and...
Track Record
We have an over 90% success rate
3rd Party Verified:
(click on the stock symbols below to see the reports)
Get Our Latest Reports Delivered To Your Inbox (we will not share your email with anyone)